White papers

White papers

 

Why do so Many Phase III Fail?

White papers

Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….

Download/View

THE IMPACT OF COVID-19 ON RANDOMIZED CLINICAL TRIALS

White papers

The COVID-19 pandemic has a major impact on the conduct of most on-going clinical trials, in particular on the treatment…

Download/View

IDDI Comments on FDA Draft Guidance on Expansion Cohorts

White papers

The need to consider randomization whenever feasible in expansion cohorts The purpose of IDDI comments on FDA Draft guidance is to…

Download/View